| Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis R Rajasingham, RM Smith, BJ Park, JN Jarvis, NP Govender, TM Chiller, ... The Lancet infectious diseases 17 (8), 873-881, 2017 | 1865 | 2017 |
| A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19 DR Boulware, MF Pullen, AS Bangdiwala, KA Pastick, SM Lofgren, ... New England journal of medicine 383 (6), 517-525, 2020 | 1558 | 2020 |
| Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial CP Skipper, KA Pastick, NW Engen, AS Bangdiwala, M Abassi, ... Annals of internal medicine 173 (8), 623-631, 2020 | 640 | 2020 |
| Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis DR Boulware, DB Meya, C Muzoora, MA Rolfes, K Huppler Hullsiek, ... New England Journal of Medicine 370 (26), 2487-2498, 2014 | 502 | 2014 |
| Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast DR Boulware, MA Rolfes, R Rajasingham, M von Hohenberg, Z Qin, ... Emerging infectious diseases 20 (1), 45, 2014 | 326 | 2014 |
| Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study NC Bahr, E Nuwagira, EE Evans, FV Cresswell, PV Bystrom, ... The Lancet infectious diseases 18 (1), 68-75, 2018 | 309 | 2018 |
| Hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19) KA Pastick, EC Okafor, F Wang, SM Lofgren, CP Skipper, MR Nicol, ... Open forum infectious diseases 7 (4), ofaa130, 2020 | 235 | 2020 |
| The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis R Rajasingham, NP Govender, A Jordan, A Loyse, A Shroufi, ... The Lancet infectious diseases 22 (12), 1748-1755, 2022 | 198 | 2022 |
| Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care R Rajasingham, DB Meya, DR Boulware JAIDS Journal of Acquired Immune Deficiency Syndromes 59 (5), e85-e91, 2012 | 184 | 2012 |
| The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis MA Rolfes, KH Hullsiek, J Rhein, HW Nabeta, K Taseera, C Schutz, ... Clinical infectious diseases 59 (11), 1607-1614, 2014 | 182 | 2014 |
| Hydroxychloroquine as pre-exposure prophylaxis for coronavirus disease 2019 (COVID-19) in healthcare workers: a randomized trial R Rajasingham, AS Bangdiwala, MR Nicol, CP Skipper, KA Pastick, ... Clinical Infectious Diseases 72 (11), e835-e843, 2021 | 167 | 2021 |
| A systematic review of behavioral and treatment outcome studies among HIV-infected men who have sex with men who abuse crystal methamphetamine R Rajasingham, MJ Mimiaga, JM White, MM Pinkston, RP Baden, JA Mitty AIDS patient care and STDs 26 (1), 36-52, 2012 | 167 | 2012 |
| Cryptococcal meningitis diagnostics and screening in the era of point-of-care laboratory testing R Rajasingham, RM Wake, T Beyene, A Katende, E Letang, DR Boulware Journal of clinical microbiology 57 (1), 10.1128/jcm. 01238-18, 2019 | 158 | 2019 |
| Improved diagnostic sensitivity for tuberculous meningitis with Xpert® MTB/RIF of centrifuged CSF NC Bahr, L Tugume, R Rajasingham, R Kiggundu, DA Williams, ... The international journal of tuberculosis and lung disease 19 (10), 1209-1215, 2015 | 134 | 2015 |
| Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis R Rajasingham, MA Rolfes, KE Birkenkamp, DB Meya, DR Boulware Public Library of Science 9 (9), e1001316, 2012 | 100 | 2012 |
| Epidemiology of meningitis in an HIV-infected Ugandan cohort R Rajasingham, J Rhein, K Klammer, A Musubire, H Nabeta, ... The American journal of tropical medicine and hygiene 92 (2), 274, 2015 | 81 | 2015 |
| Symptoms of COVID-19 outpatients in the United States MF Pullen, CP Skipper, KH Hullsiek, AS Bangdiwala, KA Pastick, ... Open forum infectious diseases 7 (7), ofaa271, 2020 | 72 | 2020 |
| Finding the dose for hydroxychloroquine prophylaxis for COVID‐19: the desperate search for effectiveness M Al‐Kofahi, P Jacobson, DR Boulware, A Matas, R Kandaswamy, ... Clinical Pharmacology & Therapeutics 108 (4), 766-769, 2020 | 66 | 2020 |
| Inadequacy of high-dose fluconazole monotherapy among cerebrospinal fluid cryptococcal antigen (CrAg)–positive human immunodeficiency virus-infected persons in an Ethiopian … T Beyene, AG Zewde, A Balcha, B Hirpo, T Yitbarik, T Gebissa, ... Clinical Infectious Diseases 65 (12), 2126-2129, 2017 | 65 | 2017 |
| Cost-effectiveness of Treatment Regimens for Clostridioides difficile Infection: An Evaluation of the 2018 Infectious Diseases Society of America Guidelines R Rajasingham, EA Enns, A Khoruts, BP Vaughn Clinical infectious diseases 70 (5), 754-762, 2020 | 62 | 2020 |
